Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Landmark MRSA (methicillin-resistant Staphylococcus aureus) damages case piles the pressure on UK NHS:

This article was originally published in Clinica

Executive Summary

A UK patient has won the first ever case for compensation from the National Health Service for contracting methicillin-resistant Staphylococcus aureus (MRSA), putting renewed pressure on the NHS to ensure it implements the applicable control measures. The case at the Princess of Wales Hospital in Bridgend, South Wales, occurred in February 2001 following a hip replacement operation. The infection resulted in the removal of the implanted hip; later bone deterioration precluded a further replacement, leaving the patient permanently disabled. The hospital reached a settlement for undisclosed "substantial damages", admitting some failings in relation to the prevention and treatment of the infection; previous compensation cases had hinged on admissions of inadequate treatment.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel